
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Ноя. 21, 2024
Язык: Английский
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Ноя. 21, 2024
Язык: Английский
Nano Trends, Год журнала: 2025, Номер unknown, С. 100119 - 100119
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0Journal of Controlled Release, Год журнала: 2025, Номер unknown, С. 113829 - 113829
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0International Journal of Nanomedicine, Год журнала: 2024, Номер Volume 19, С. 12793 - 12815
Опубликована: Ноя. 1, 2024
Plant-derived exosome-like nanovesicles (PELNs) from edible plants, isolated by ultracentrifugation, size exclusion chromatography or other methods, were proved to contain a variety of biologically active and therapeutically specific components. Recently, investigations in the field PELN-based biomedicine have been conducted, which positioned those as promising tools for prevention treatment several diseases, with their natural origin potentially offering superior biocompatibility bioavailability. However, inadequate targeting limited therapeutic effects constrain utility clinical translation PELNs. Thus, strategies aiming at bridging gap engineering PELNs great interest. Those approaches include membrane hybridization, physical chemical surface functionalization encapsulation payloads. Herein, we provide comprehensive overview biogenesis composition, isolation purification methods characterization PELNs, well functions. Current knowledge on construction biomedical application engineered reviewed. Additionally, future directions perspectives this discussed order further enrich expand prospects
Язык: Английский
Процитировано
2International Journal of Nanomedicine, Год журнала: 2024, Номер Volume 19, С. 13217 - 13233
Опубликована: Дек. 1, 2024
The treatment of glioblastoma is hindered by the blood-brain barrier (BBB) and rapid drug clearance immune system. To address these challenges, we propose a novel delivery system using liposomes modified with cell membrane fragments. These can evade system, cross BBB, accumulate in tumor tissue through homotypic targeting, thereby delivering drugs like paclitaxel carboplatin more effectively.
Язык: Английский
Процитировано
1Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Ноя. 21, 2024
Язык: Английский
Процитировано
0